BHVN
Biohaven Ltd. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +7.1% ·
share flow -9.5% ·
net new positions +6.7%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 94 | +2 | 76.78M | $1.14B | +6 | −4 |
| Q1 2026 | 95 | 0 | 88.72M | $750.66M | +4 | −4 |
| Q4 2025 | 95 | -1 | 70.26M | $793.21M | +1 | −2 |
| Q3 2025 | 19 | +1 | 32.20M | $483.28M | +2 | −2 |
| Q2 2025 | 16 | -1 | 31.66M | $446.69M | — | −1 |
| Q1 2025 | 14 | -1 | 13.40M | $322.18M | — | −1 |
| Q4 2024 | 15 | +1 | 14.58M | $544.70M | +1 | — |
| Q3 2024 | 13 | 0 | 12.61M | $630.01M | — | — |
| Q2 2024 | 13 | — | 11.04M | $383.32M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 3.51M | — | $131.19M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 3.41M | -0.8% | $127.45M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 3.41M | -0.8% | $127.45M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.91M | +11.1% | $71.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 1.91M | +11.1% | $71.18M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.75M | -0.4% | $65.30M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.75M | -0.4% | $65.30M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 922.97K | -38.5% | $34.47M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 9 | Norges Bank ✦ (passive) | 902.57K | +18.2% | $33.71M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 634.05K | +160.8% | $23.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 634.05K | +160.8% | $23.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 634.05K | +160.8% | $23.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 634.05K | +160.8% | $23.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 634.05K | +160.8% | $23.68M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Adage Capital Partners ✦ | 575.00K | -61.2% | $21.48M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Marshall Wace ✦ | 366.89K | -1.3% | $13.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Marshall Wace ✦ | 366.89K | -1.3% | $13.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Marshall Wace ✦ | 366.89K | -1.3% | $13.70M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Capital World Investors ✦ | 250.00K | 0.0% | $9.34M | 0.0% | Held | 3 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 170.65K | -70.5% | $6.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 170.65K | -70.5% | $6.37M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Two Sigma Investments ✦ | 80.86K | -71.2% | $3.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 76.87K | +51.2% | $2.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | AQR Capital Management ✦ | 76.87K | +51.2% | $2.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 25 | AQR Capital Management ✦ | 76.87K | +51.2% | $2.87M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 26 | Renaissance Technologies ✦ | 19.35K | New | $722,797 | 0.0% | New | 1 | SEC ↗ |
| 27 | Millennium Management ✦ | 5.80K | -96.8% | $216,667 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $722,797 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 51.20K shares, $433 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.